Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Merit Medical Systems, Inc.

Stage 2 · Advancing · week 9

As of Oct 22, 2026, Merit Medical Systems is in Stage 2, the uptrend phase, now in week 9 (since Aug 20, 2026). It closed at $93.94, at its 52-week high and above its 200-day average, which is rising.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germ… More about the company

$93.94
+2.78% today
$5.6B · Mid cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 18 in Medical Instruments & Supplies · #1 of 272 in Health Care

Is MMSI early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 46w
S4 32w
S4 23w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S3 3w → S4 10w → S1 11w → S2 8w → S3 8w → S2 46w → S3 3w → S4 32w → S1 6w → S4 23w → S1 5w → S2 9w current
Total tracked: 166 weeks across 12 stage runs.

MMSI among Medical Instruments & Supplies18th of 51 by relative strength

All 51 →
Stocks in Medical Instruments & Supplies ranked by relative strength, with stage and one-month change
#StockStageRS1M
1PLSEStage 2 · wk 3498+1.3%
2PDEXStage 2 · wk 3697−13.3%
3HBIOStage 2 · wk 1195+3.6%
4ATRCStage 2 · wk 1089−1.1%
5WSTStage 2 · wk 2482+4.8%
6BDXStage 2 · wk 1181+9.8%
7ICUIStage 3 · wk 181+3.1%
8OSURStage 3 · wk 875−4.8%
…18MMSIStage 2 · wk 963+7.9%
vs 52W High
0.0%
$60.31 lo$93.94 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 9
1w13w26w
Week 9, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
22.4%
200 DMA: $76.77 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
1.03x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
Short-term trend rising gently
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+7.9%
3M
+26.4%
6M
+36.9%
YTD
+8.7%
1Y
+11.6%
Scan Membership
Breakout Watch
Latest: 2024-05-21
8 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 9 · Vol 1.03x
2026-10-21S2
Wk 9 · Vol 0.64x
2026-10-20S2
Wk 9 · Vol 1.04x
2026-10-19S2
Wk 9 · Vol 0.86x
2026-10-16S2
Wk 9 · Vol 0.71x
2026-10-15S2
Wk 8 · Vol 0.99x
2026-10-14S2
Wk 8 · Vol 0.83x
2026-10-13S2
Wk 8 · Vol 1.13x
2026-10-12S2
Wk 8 · Vol 1.11x
2026-10-09S2
Wk 8 · Vol 0.60x
2026-10-08S2
Wk 7 · Vol 0.71x
2026-10-07S2
Wk 7 · Vol 0.56x
Moving averages & range
50 DMA
$88.39
200 DMA
$76.77
52W High
$93.94
52W Low
$60.31
5D Low
$89.20
Resistance levels (recent highs)
20d High
$93.94
60d High
$93.94
120d High
$93.94
250d High
$93.94
Next resistance
Above all
P/E (TTM)
38.7
Forward 20.4
Earnings Growth (YoY)
+20.4%
Revenue +9.5%
ROE
+9.2%
Profit margin +9.2%
Dividend Yield
0.00%
P/B 3.3

Merit Medical Systems: quick answers

What stage is Merit Medical Systems in?

As of Oct 22, 2026, Merit Medical Systems (MMSI) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 20, 2026 and is in week 9. What the four stages mean

Is Merit Medical Systems in an uptrend?

Yes. Merit Medical Systems is in a Stage 2 uptrend. It trades 22.4% above its 200-day average, which is rising.

How far is Merit Medical Systems from its 52-week high?

Merit Medical Systems closed at $93.94 on Oct 22, 2026, at its 52-week high. Its 52-week low is $60.31.

How has Merit Medical Systems performed over the past year?

As of Oct 22, 2026, Merit Medical Systems is up 11.6% over the past year and up 8.7% so far in 2026.

Which sector and industry is Merit Medical Systems in?

Merit Medical Systems is in the Medical Instruments & Supplies industry, part of the Health Care sector.

About this companyHealth Care· Medical Instruments & Supplies

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.